Literature DB >> 15482157

Pathogenesis of Guillain-Barre syndrome.

Raymond Sw Tsang1, Alfonso Valdivieso-Garcia.   

Abstract

Guillain-Barre syndrome is a postinfectious disorder caused by an aberrant immune response to an infectious pathogen, resulting in an autoimmune disease. As with other autoimmune diseases of infectious nature, the intricate balance of the numerous factors involved in the immune response may determine the outcome of the interaction between the microbe and host. Recent studies focusing on the role of cytokines and its network of related mediators and receptors suggest that any imbalance may make a significant contribution to the outcome of the infectious disease process. Better understanding of the pathogenesis of Guillain-Barre syndrome may lead to the discovery of newer therapeutics and may also serve as a model for studying other autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15482157     DOI: 10.1586/14787210.1.4.597

Source DB:  PubMed          Journal:  Expert Rev Anti Infect Ther        ISSN: 1478-7210            Impact factor:   5.091


  6 in total

1.  Investigation of effects of two-different treatment modalities on nerve conduction in patients with ankylosing spondylitis.

Authors:  Erhan Capkin; Murat Karkucak; Muammer Muslim Kose; Vildan Altunayoğlu Çakmak; Aysegul Kucukali Turkyilmaz; Mehmet Tosun
Journal:  Rheumatol Int       Date:  2010-12-01       Impact factor: 2.631

2.  First case of demyelinating polyneuropathy probably related to treatment with golimumab.

Authors:  Francisco Javier Domínguez Díez
Journal:  Eur J Rheumatol       Date:  2018-06-22

Review 3.  The role of chemokines in Guillain-Barré syndrome.

Authors:  Sharon Chiang; Eroboghene E Ubogu
Journal:  Muscle Nerve       Date:  2013-07-27       Impact factor: 3.217

Review 4.  Severe Guillain-Barré syndrome in a patient receiving anti-TNF therapy. Consequence or coincidence. A case-based review.

Authors:  Bonifacio Alvarez-Lario; Rosa Prieto-Tejedo; María Colazo-Burlato; Jesús Macarrón-Vicente
Journal:  Clin Rheumatol       Date:  2013-05-11       Impact factor: 2.980

Review 5.  Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.

Authors:  Kenichi Kaida; Toshio Ariga; Robert K Yu
Journal:  Glycobiology       Date:  2009-02-24       Impact factor: 4.313

6.  Chronic Inflammatory Demyelinating Polyneuropathy Following Anti-TNF-α Therapy With Infliximab for Crohn's Disease.

Authors:  Amir Y Kamel; Orestes Concepcion; Alexander Schlachterman; Sarah Glover; Christopher Y Forsmark
Journal:  ACG Case Rep J       Date:  2016-04-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.